| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $87.2M | -5.1% |
| Gross Profit | $11.9M | -0.5% |
| R&D Expense | $5.8M | -56.3% |
| SG&A Expense | $49.5M | -30.5% |
| Operating Income | -$84.8M | +32.1% |
| Pre-tax Income | -$73.7M | +45.3% |
| Income Tax | -$3.2M | -109.5% |
| Net Income | -$74.0M | +56.2% |
| EPS (Basic) | -$0.19 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $669.3M | -12.5% |
| Short-term Investments | $192.2M | +70.0% |
| Accounts Receivable | $14.0M | -39.5% |
| Inventory | $30.5M | -18.8% |
| Current Assets | $933.3M | -2.8% |
| Total Assets | $1.14B | -6.0% |
| Current Liabilities | $41.4M | -39.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.8M | +51.8% |
| Capital Expenditures | $2.5M | -27.4% |
| Investing Cash Flow | -$59.5M | -3130.1% |
| Financing Cash Flow | -$1.0M | +64.4% |
| Free Cash Flow | -$45.3M | +50.9% |
| +57.8% |
| EPS (Diluted) | -$0.19 | +57.8% |
| Total Liabilities |
| $44.0M |
| -39.0% |
| Stockholders' Equity | $1.10B | -3.9% |